Morphosys AG reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Morphosys AG announced earnings per share of €6.11 on revenue of €251.2M. Analysts polled by anticipated EPS of €3.16 on revenue of €174.5M. That with comparison to EPS of €-0.72 on revenue of €13.5M in the same period a year before. Morphosys AG had reported EPS of €-1.59 on revenue of €11.1M in the previous quarter. Analysts are expecting EPS of €-0.66 and revenue of €37.22M in the upcoming quarter.
Morphosys AG shares are down 29% from the beginning of the year , still down 30.26% from its 52 week high of €146.30 set on January 13. They are under-performing the STOXX 600 which is down 19.73% year to date.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings beat by Bayer on April 27, who reported EPS of €2.67 on revenue of €12.85B, compared to forecasts EPS of €2.52 on revenue of €12.57B.
Siemens Healthineers had beat expectations on Tuesday with second quarter EPS of €0.43 on revenue of €3.69B, compared to forecast for EPS of €0.4 on revenue of €3.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
